文献速递糖尿病

诊断年龄不影响严格定义成人起病1型糖尿病的表现或进展

Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2023-01-01

在StartRight前瞻性研究的1798例新发糖尿病成人中,比较诊断年龄与表现、C肽年下降及遗传风险的关系。严格定义成人起病1型糖尿病后,诊断年龄与C肽下降、基线C肽及遗传风险评分均无关(P>0.1);诊断年龄<35岁与≥35岁者的表现严重程度相似,但年龄较大者被诊断为1型糖尿病、接受胰岛素治疗或住院的可能性更低。

要点

  • 诊断年龄与C肽年下降无关(P>0.1),<35岁与≥35岁者降幅相似。
  • 诊断年龄<35岁与≥35岁者的基线C肽和1型糖尿病遗传风险评分无差异(P>0.1)。
  • 年龄较大者虽表现相似,但被诊断为1型糖尿病、接受胰岛素治疗或住院的可能性更低。

核心结论

  • 当成人起病1型糖尿病被严格定义时,其表现特征、进展和1型糖尿病遗传易感性不因诊断年龄而改变。

研究设计与样本

  • 前瞻性StartRight研究纳入1798例新发糖尿病成人,其中严格定义1型糖尿病者:≥2种胰岛自身抗体阳性者385例(不论临床诊断),或1种自身抗体阳性且临床诊断为1型糖尿病者180例。

主要发现

  • 连续分析中,两种1型糖尿病定义下诊断年龄均与C肽下降无关(P>0.1);≥2种自身抗体阳性者中,<35岁与≥35岁诊断者的年均C肽下降分别为39%(95%CI 31-46)与44%(95%CI 38-50),临床诊断且1种自身抗体阳性者分别为43%(95%CI 33-51)与39%(95%CI 31-46)(P>0.1)。
  • 基线C肽和1型糖尿病遗传风险评分不受诊断年龄或1型糖尿病定义影响(P>0.1)。
  • 在≥2种自身抗体阳性的1型糖尿病中,<35岁与≥35岁诊断者的表现严重程度相似:非刻意体重下降分别为80%(95%CI 74-85)与82%(95%CI 76-87);酮症酸中毒分别为24%(95%CI 18-30)与19%(95%CI 14-25);就诊血糖分别为21 mmol/L(95%CI 19-22)与21 mmol/L(95%CI 20-22)(所有P≥0.1)。
  • 尽管表现相似,年龄较大者被诊断为1型糖尿病、接受胰岛素治疗或住院的可能性更低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether presentation, progression, and genetic susceptibility of robustly defined adult-onset type 1 diabetes (T1D) are altered by diagnosis age. RESEARCH DESIGN AND METHODS: We compared the relationship between diagnosis age and presentation, C-peptide loss (annual change in urine C-peptide-creatinine ratio [UCPCR]), and genetic susceptibility (T1D genetic risk score [GRS]) in adults with confirmed T1D in the prospective StartRight study, 1,798 adults with new-onset diabetes. T1D was defined in two ways: two or more positive islet autoantibodies (of GAD antibody, IA-2 antigen, and ZnT8 autoantibody) irrespective of clinical diagnosis (n = 385) or one positive islet autoantibody and a clinical diagnosis of T1D (n = 180). RESULTS: In continuous analysis, age of diagnosis was not associated with C-peptide loss for either definition of T1D (P > 0.1), with mean (95% CI) annual C-peptide loss in those diagnosed before and after 35 years of age (median age of T1D defined by two or more positive autoantibodies): 39% (31-46) vs. 44% (38-50) with two or more positive islet autoantibodies and 43% (33-51) vs. 39% (31-46) with clinician diagnosis confirmed by one positive islet autoantibody (P > 0.1). Baseline C-peptide and T1D GRS were unaffected by age of diagnosis or T1D definition (P > 0.1). In T1D defined by two or more autoantibodies, presentation severity was similar in those diagnosed before and after 35 years of age: unintentional weight loss, 80% (95% CI 74-85) vs. 82% (76-87); ketoacidosis, 24% (18-30) vs. 19% (14-25); and presentation glucose, 21 mmol/L (19-22) vs. 21 mmol/L (20-22) (all P ≥ 0.1). Despite similar presentation, older adults were less likely to be diagnosed with T1D, insulin-treated, or admitted to hospital. CONCLUSIONS: When adult-onset T1D is robustly defined, the presentation characteristics, progression, and T1D genetic susceptibility are not altered by age of diagnosis.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Thomas NJ, Hill AV, Dayan CM, et al. Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes. Diabetes Care. 2023. PMID: 36802355. doi:10.2337/dc22-2159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。